Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Fujitsu PR ....Brent
Reply New Message
Back To Forum List View

RE: Fujitsu PR ....Brent

posted on Apr 18, 2006 02:24PM
Not sure where you are going with this but the second dividend is approximately $15 million not $22 million.
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply